Atlas Trials

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers

Clinical trial NCT05549583 · COMPLETED

Trial details

NCT number
NCT05549583
Sponsor
Galenicum Health
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
BioequivalenceType 2 Diabetes
Start date
2018-04-15
Primary completion
2018-04-25
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.